Keynote Speakers


More speakers will be announced soon.

Alicia Danforth bio photo

Alicia Danforth

Alicia Danforth, PhD, is a clinical psychologist and psychedelics researcher. She began working in research with psychedelics in 2004 on the pilot study of psilocybin treatment for cancer-related anxiety at the Harbor-UCLA Medical Center. She was an investigator for the pilot study of MDMA-assisted therapy for social anxiety in autistic adults, and she was a lead clinician for the pilot study of psilocybin-assisted group therapy for demoralization in long-term survivors of HIV at UC San Francisco. She currently is bookending her research career with a return to psilocybin in palliative care, with a new emphasis on training. For her “day job,” Alicia runs a private practice in California tailored to the needs and preferences of autistic adults.

James Davies bio photo

James Davies

Dr. James Davies has a PhD from the University of Oxford in social and medical anthropology. He is now a Reader in Social Anthropology and Psychology at the University of Roehampton, London. He has practiced as a psychotherapist in the NHS, England. He is the co-founder of the Council for Evidence-based Psychiatry (CEP), which is secretariat to the All Party Parliamentary Group for Prescribed Drug Dependence (Westminster, London). He has also been an expert drug advisor for the UK government. He is the author of Cracked: the unhappy truth about psychiatry, and the more recent Sedated: why capitalism caused our mental health crisis. He has published academic books with Stanford University Press, Sage, Palgrave Macmillan and Routledge, while is articles have appeared in The Times, The New Scientist, The Guardian, The Daily Mail, Harvard Divinity Bulletin, Therapy Today, Mad in America and Salon. He has spoken widely in the media, and has also extensively consulted for the BBC and ITV., and other media outlets.

William Leonard Pickard bio photo

William Leonard Pickard

Alleged to have produced “90% of the world’s LSD,” William Leonard Pickard is a former drug policy fellow at the Kennedy School of Government at Harvard, research associate at Harvard Medical School, and deputy director of the Drug Policy Analysis Program at UCLA. His 1996 prediction of the fentanyl epidemic, and recommendations for prevention, occurred two decades before the event. The RAND Corporation discussed PIckard’s work in its seminal “The Future of Fentanyl and Other Synthetic Opioids.” Given two life sentences without possibility of parole, Pickard served 20 years in maximum security federal prisons. In 2020, he was granted compassionate release. Presently, Pickard is a senior advisor to the biotechnology venture firm JLS Fund and to the Fireside Project.